Clinical Trial Update: A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ABI-H0731+Entecavir versus Entecavir alone in viremic HBeAg-positive chronic hepatitis B showed completion and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ABI-H0731
• ENTECAVIR (ENTECAVIR)

Snippet

Sponsor: Assembly Biosciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2021-01-28